Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Mayo Clin Proc. 2019 Jun 27;94(9):1753–1768. doi: 10.1016/j.mayocp.2019.04.007

Figure 2:

Figure 2:

Figure representing a visual description of the different diagnoses included in our cohort of patients with unexplained cytopenias. We divided the patients into three primary categories; IBMFS (n=24, 35%), cytopenias without a known clinical syndrome (n=30, 44%) and other patients which did not fit either of the two categories (n=14, 21%). Abbreviations: IBMFS = inherited bone marrow failure syndromes; STS = short telomere syndromes; DBA = Diamond-Blackfan anemia; DADA2 = deficiency of adenosine deaminase-2; SCN = severe congenital neutropenia; FA: Fanconi’s anemia; ICUS = idiopathic cytopenias of undetermined significance; CCUS = clonal cytopenias of undetermined significance; FMPD = familial myeloid predisposition; BMFS = bone marrow failure syndromes.